BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23148639)

  • 1. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
    Mishra PJ; Bertino JR
    Pharmacogenomics; 2009 Mar; 10(3):399-416. PubMed ID: 19290790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors.
    Nakajima M; Yokoi T
    Pharmacol Ther; 2011 Sep; 131(3):330-7. PubMed ID: 21565218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
    Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.
    Rukov JL; Shomron N
    Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs as mediators of drug toxicity.
    Yokoi T; Nakajima M
    Annu Rev Pharmacol Toxicol; 2013; 53():377-400. PubMed ID: 23189953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of microRNAs in personalized medicine.
    Avci CB; Baran Y
    Methods Mol Biol; 2014; 1107():311-25. PubMed ID: 24272446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in gastrointestinal tumors.
    Stöhlmacher J
    Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How genetic variation affects patient response and outcome to therapy for psoriasis.
    Woolf RT; Smith CH
    Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
    Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
    J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenomics and the path towards personalized medicine].
    Belloso WH; Redal MA
    Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and personalized medicine.
    Tang J; Xiong Y; Zhou HH; Chen XP
    J Clin Pharm Ther; 2014 Dec; 39(6):621-7. PubMed ID: 25230364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.